US5651869A - Biosensor - Google Patents

Biosensor Download PDF

Info

Publication number
US5651869A
US5651869A US08/605,391 US60539196A US5651869A US 5651869 A US5651869 A US 5651869A US 60539196 A US60539196 A US 60539196A US 5651869 A US5651869 A US 5651869A
Authority
US
United States
Prior art keywords
reaction layer
biosensor
substrate
glucose
pyranose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/605,391
Inventor
Toshihiko Yoshioka
Shin Ikeda
Shiro Nankai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHC Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Assigned to MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. reassignment MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IKEDA, S., NANKAI, S., YOSHIOKA, T.
Application granted granted Critical
Publication of US5651869A publication Critical patent/US5651869A/en
Assigned to PANASONIC CORPORATION reassignment PANASONIC CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
Assigned to PANASONIC HEALTHCARE CO., LTD. reassignment PANASONIC HEALTHCARE CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PANASONIC CORPORATION
Assigned to PANASONIC CORPORATION reassignment PANASONIC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PANASONIC HEALTHCARE CO., LTD.
Assigned to PHC HOLDINGS CO., LTD. reassignment PHC HOLDINGS CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PANASONIC CORPORATION
Assigned to PANASONIC HEALTHCARE HOLDINGS CO., LTD. reassignment PANASONIC HEALTHCARE HOLDINGS CO., LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: PHC HOLDINGS CO., LTD.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/004Enzyme electrodes mediator-assisted
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/817Enzyme or microbe electrode

Definitions

  • the present invention relates to a biosensor for quantitating a substrate (specific component) contained in a sample liquid such as whole blood, plasma, serum, urine, fruit juice and the like, with accuracy, speed and ease. More particularly, the invention relates to a glucose sensor for electrochemically measuring a concentration of glucose included in a sample liquid by reacting the glucose with an oxidoreductase which can react with specificity to the glucose.
  • biosensors which can easily quantitate a specific component (substrate) in a sample liquid such as a biological sample and food without diluting and stirring the sample liquid.
  • Japanese Laid-Open Patent Publication No. 3-202764 discloses a biosensor comprising an electrode system formed on an insulating substrate by screen printing or the like and a reaction layer formed on the electrode system and including a hydrophilic polymer, an oxidoreductase, and an electron acceptor.
  • concentration of a substrate in a sample liquid is measured by using this biosensor as follows. First, the sample liquid is dropped on the reaction layer of the biosensor, so as to dissolve the reaction layer. This causes an enzyme reaction between the substrate in the sample liquid and the oxidoreductase in the reaction layer, and then, the electron acceptor in the reaction layer is reduced. After the completion of the enzyme reaction, the reduced electron acceptor is electrochemically oxidized, thereby measuring the concentration of the substrate in the sample liquid based on an oxidation current value obtained in this oxidation.
  • U.S. Pat. No. 5,192,415 discloses a biosensor comprising a hydrogen ion concentration control layer which can optimize the pH of the sample liquid depending upon the type of oxidoreductase contained in a reaction layer without previously adjusting the pH of a sample liquid.
  • U.S. Pat. No. 5,264,103 discloses a biosensor comprising a main electrode system formed on an electrically insulating substrate and including a working electrode and a counter electrode; a reaction layer including an oxidoreductase; and a sub electrode layer provided with an interval from the main electrode system and including a working electrode and a counter electrode.
  • biosensors can be used in a wide range of applications, for example as, a glucose sensor, an alcohol sensor, a cholesterol sensor, or an amino acid sensor by appropriately selecting an oxidoreductase to be contained in the reaction layer.
  • a glucose sensor is generally known to include glucose oxidase as the oxidoreductase.
  • glucose oxidase As the oxidoreductase.
  • Such a glucose sensor has, however, the following problem.
  • isomers of glucose glucose oxidase reacts to ⁇ -glucose alone which exists at a proportion of 63% in the equilibrium state. Therefore, a response current value (i.e., detection sensitivity) obtained by such a glucose sensor is so small that measurement error is large, for example, in quantitating an extremely small amount of glucose.
  • Japanese Patent Application No. 6-291401 (unpublished) relates to a biosensor including both mutarotase and glucose oxidase.
  • the detection sensitivity cannot be sufficiently improved when the total amount of these enzymes is small, and the production cost is increased when the total amount of the enzymes is large.
  • the biosensor including mutarotase and glucose oxidase has lower detection sensitivity as compared with a biosensor excluding mutarotase.
  • the biosensor of the present invention comprises an electrically insulating substrate; an electrode system formed on the substrate which includes a working electrode and a counter electrode; and a reaction layer formed on the substrate or above the substrate with a space therebetween.
  • the reaction layer includes a pyranose-oxidizing enzyme.
  • the pyranose-oxidizing enzyme is pyranose oxidase (EC1.1.3.10).
  • reaction layer further includes glucose oxidase (EC1.1.3.4).
  • reaction layer further includes an electron acceptor.
  • the electron acceptor is a ferricyanide ion.
  • reaction layer further includes polysaccharide hydrolase.
  • the polysaccharide hydrolase is one selected from the group consisting of sucrose hydrolase, maltose hydrolase, and lactose hydrolase.
  • the content of the pyranose-oxidizing enzyme is 1 to about 200 units per 1 cm 2 of the reaction layer.
  • the content of the pyranose-oxidizing enzyme is about 0.1 to about 200 units per 1 cm 2 of the reaction layer.
  • the contents of the pyranose-oxidizing enzyme and the ferricyanide ion are 1 to about 200 units and about 0.21 mg to about 3.30 mg, respectively per 1 cm 2 of the reaction layer.
  • the contents of the pyranose-oxidizing enzyme, the glucose oxidase and the ferricyanide ion are about 0.1 to about 200 units, 1 to about 200 units, and about 0.21 mg to about 3.30 mg, respectively per 1 cm 2 of the reaction layer.
  • the biosensor is used for measuring a blood glucose level.
  • the biosensor of the present invention for quantitating a substrate included in a sample liquid by reducing an electron acceptor with an electron generated through an enzyme reaction of the substrate and electrochemically measuring an amount of a reduced form of the electron acceptor, comprises an electrically insulating substrate; an electrode system formed on the substrate and including a working electrode and a counter electrode; and a reaction layer formed on the substrate or above the substrate with a space therebetween.
  • the reaction layer includes a pyranose-oxidizing enzyme and the electron acceptor.
  • the reaction layer further includes glucose oxidase (EC1.1.3.4).
  • the biosensor is a glucose sensor.
  • the biosensor is used for measuring a blood glucose level.
  • the invention described herein makes possible the advantages of (1) providing a biosensor which can measure the concentration of a substrate in a sample liquid with accuracy and speed by simultaneously detecting ⁇ -glucose and ⁇ -glucose; (2) providing a biosensor which can easily measure the concentration of a substrate in a sample liquid including polysaccharide; and (3) providing a biosensor which can be manufactured at a low cost.
  • FIG. 1 is a schematic plane view of a biosensor as an example of the invention in which a reaction layer is omitted;
  • FIG. 2 is a schematic sectional view of a biosensor as an example of the invention in which a reaction layer is directly disposed on a substrate;
  • FIG. 3 is a schematic sectional view of a biosensor as another example of the invention in which a reaction layer is disposed above a substrate with a space therebetween;
  • FIG. 4 is a graph showing the relationship between the concentration of glucose and a response current value obtained by biosensors according to an example and comparative examples of the invention; wherein a curve (a) shows the change of a response current value obtained by using a reaction layer including pyranose oxidase (hereinafter referred to as PyOx) and glucose oxidase (hereinafter referred to as GOD), a curve (b) shows the change of a response current value obtained by using a reaction layer including GOD alone, and a curve (c) shows the change of a response current value obtained by using a reaction layer including PyOx alone; and
  • a curve (a) shows the change of a response current value obtained by using a reaction layer including pyranose oxidase (hereinafter referred to as PyOx) and glucose oxidase (hereinafter referred to as GOD)
  • a curve (b) shows the change of a response current value obtained by using a reaction layer including GOD alone
  • FIG. 5 is a graph showing the relationship between the concentration of blood glucose and a response current value obtained by glucose sensors according to an example and comparative examples of the invention; wherein a curve (a) shows the change of a response current value obtained by using a reaction layer including PyOx and GOD, a curve (b) shows the change of a response current value obtained by using a reaction layer including GOD alone as an oxidoreductase, and a curve (c) shows the change of a response current value obtained by using a reaction layer including PyOx alone.
  • a curve (a) shows the change of a response current value obtained by using a reaction layer including PyOx and GOD
  • a curve (b) shows the change of a response current value obtained by using a reaction layer including GOD alone as an oxidoreductase
  • a curve (c) shows the change of a response current value obtained by using a reaction layer including PyOx alone.
  • a biosensor of this invention comprises an electrically insulating substrate, an electrode system formed on the substrate which includes a working electrode and a counter electrode, and a reaction layer formed either on the substrate or above the substrate with a space therebetween.
  • the electrically insulating substrate is made from a plate of a synthetic resin such as polyethylene terephthalate, polyethylene, polyester, polypropylene, polystyrene, and polyvinyl chloride.
  • a synthetic resin such as polyethylene terephthalate, polyethylene, polyester, polypropylene, polystyrene, and polyvinyl chloride.
  • the electrode system including the working electrode and the counter electrode can be formed on the substrate by a known method. For example, after forming leads on the substrate, the working electrode and the counter electrode are formed so as to be connected to the respective leads and be insulated from each other.
  • the materials for the leads and the electrodes can be any of known conductive materials such as carbon, silver, platinum, gold, and palladium.
  • the reaction layer used in the present biosensor includes a pyranose-oxidizing enzyme, which can simultaneously oxidize both ⁇ -glucose and ⁇ -glucose.
  • a pyranose-oxidizing enzyme includes pyranose oxidase (EC1.1.3.10; PyOx).
  • the content of PyOx in the reaction layer of the present biosensor is preferably 1 to about 200 units, and more preferably about 2 to about 50 units per 1 cm 2 of the reaction layer.
  • the term "unit” herein refers to the amount of an oxidoreductase necessary for oxidizing 1 ⁇ mol of glucose or polysaccharide in one minute.
  • an additional time of several minutes or more is required for the measurement.
  • the response current value can be affected.
  • a content of PyOx exceeding about 200 units per 1 cm 2 of the reaction layer not only increases the production cost but also causes fluctuation in response current values because the reaction layer can be broken during the formation thereof.
  • the reaction layer can include glucose oxidase (EC1.1.3.4; GOD), in addition to the pyranose-oxidizing enzyme, in order to further improve the detection sensitivity against glucose in a sample liquid and to enable the glucose sensor to response to a wider range of glucose concentration.
  • GOD glucose oxidase
  • the content of GOD is preferably 1 to about 200 units per 1 cm 2 of the reaction layer.
  • the content of PyOx is preferably about 0.1 to about 200 units, and more preferably about 0.2 to about 40 units per 1 cm 2 of the reaction layer.
  • the reaction layer can further include various hydrophilic polymers.
  • hydrophilic polymer include carboxy methyl cellulose (hereinafter referred to as CMC), hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), methyl cellulose, ethyl cellulose, ethyl hydroxyethyl cellulose, carboxymethyl ethyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, polyamino acids such as polylysine, polystyrenesulfonic acid, gelatin or its derivatives, acrylic acid or its salts, methacrylic acid or its salts, starch or its derivatives, and maleic anhydride or its salt.
  • CMC is preferred.
  • ⁇ -glucose and ⁇ -glucose in the sample liquid are respectively oxidized by the pyranose-oxidizing enzyme. Simultaneously, dissolved oxygen in the sample liquid is reduced into hydrogen peroxide. When a voltage is applied at this point, the hydrogen peroxide is oxidized. A response current generated in this oxidation is in proportion to the concentration of the hydrogen peroxide, i.e., the concentration of the substrate in the sample liquid. Thus, the concentration of the substrate in the sample liquid can be obtained by measuring the response current value.
  • the reaction layer can include an electron acceptor so as to form a reduced form of the electron acceptor simultaneously with the enzyme reaction, in stead of producing hydrogen peroxide simultaneously with the oxidation reaction of the substrate.
  • the electron acceptor include a ferricyanide ion, p-benzoquinone or its derivatives, phenazine methosulfate, Methylene Blue, and ferrocene or its derivative.
  • One or more of the electron acceptor can be used.
  • a ferricyanide ion is preferred.
  • the content of the ferricyanide ion is preferably about 0.21 to about 3.30 mg, and more preferably about 0.30 to about 2.59 mg per 1 cm 2 of the reaction layer.
  • the content of the ferricyanide ion is smaller than about 0.21 mg per 1 cm 2 of the reaction layer, the measurable range of the glucose concentration can be extremely small.
  • the content of the ferricyanide ion exceeds about 3.30 mg per 1 cm 2 of the reaction layer, fluctuation of response current values can be caused because the reaction layer can be broken during the formation thereof, and the reliability of the biosensor can be degraded while it is stored.
  • the reaction layer used in the present biosensor can further include a polysaccharide hydrolase for hydrolyzing a polysaccharide to produce ⁇ -glucose.
  • the polysaccharide hydrolase is an enzyme capable of hydrolyzing a polysaccharide such as sucrose and maltose to produce glucose.
  • examples of such polysaccharide hydrolase include sucrose hydrolase such as invertase (hereinafter referred to as INV), maltose hydrolase such as maltase, and lactose hydrolase such as ⁇ -galactosidase.
  • the content of the polysaccharide hydrolase is preferably 1 to about 400 units, and more preferably about 2 to about 200 units per 1 cm 2 of the reaction layer.
  • FIGS. 1 and 2 A production method for the present biosensor will now be described referring to FIGS. 1 and 2.
  • a conductive material such as silver paste is printed on an electrically insulating substrate 1 by screen printing, thereby forming leads 2 and 3.
  • another conductive material including a resin binder is printed on the substrate 1, thereby forming a working electrode 4, so as to be in contact with the lead 2.
  • insulating paste is printed on the substrate 1, thereby forming an insulating layer 6.
  • the insulating layer 6 covers the peripheral portion of the working electrode 4, so as to expose a fixed area of the working electrode 4. As is shown in FIG. 1, the insulating layer 6 also covers part of the leads 2 and 3.
  • a ring-shaped counter electrode 5 out of a conductive material including a resin binder.
  • the counter electrode 5 is in contact with the lead 3.
  • an electrode system 8 including the working electrode 4 and the counter electrode 5 is formed on the substrate 1.
  • the present biosensor can comprise a three-electrode system formed on the substrate 1 including a reference electrode (not shown) in addition to the working electrode 4 and the counter electrode 5, for the purpose of further stabilizing the measurement accuracy.
  • a reaction layer is formed on the substrate 1 as follows:
  • aqueous solution of the hydrophilic polymer is dropped and dried on the electrode system 8, thereby forming a hydrophilic polymer layer. Then, an aqueous solution including PyOx, and the electron acceptor and/or the polysaccharide hydrolase, if necessary, is dropped and dried on the hydrophilic polymer layer.
  • the pyranose-oxidizing enzyme, and the polysaccharide hydrolase can be immobilized on the hydrophilic polymer layer through crosslinking with glutaraldehyde or immobilized on the hydrophilic polymer layer together with a polymeric material such as nitrocellulose, cellulose acetate, and polyacrylonitrile.
  • the electron acceptor can be chemically fixed on the hydrophilic polymer layer by using the polymeric material, if necessary.
  • a reaction layer 7 covering the entire electrode system 8 as shown in FIG. 2 can be formed.
  • the reaction layer can be disposed above the substrate 1 with a space therebetween.
  • the biosensor comprises the substrate 1 and a cover 30 disposed above the substrate 1 with a spacer 20 sandwiched therebetween.
  • the cover 30 includes a hole 31 and a reaction layer 37 formed on one surface thereof.
  • the cover 30 is disposed above the substrate 1 so as to oppose the reaction layer 37 and the electrode system 8 to each other.
  • Such a reaction layer 37 disposed above the substrate 1 with a space therebetween can be formed as described in, for example, Japanese Laid-Open Patent Publication No. 1-114747.
  • the present biosensor can be used for quantitating various kinds of substrates included in a biological sample such as whole blood, plasma, serum, and urine, materials of the food industry and product thereof, for example fruit juice.
  • a biological sample such as whole blood, plasma, serum, and urine
  • materials of the food industry and product thereof for example fruit juice.
  • the present biosensor can serve as a disposable blood glucose sensor which can be easily used.
  • a glucose sensor was manufactured as follows:
  • silver paste was printed by screen printing on an electrically insulating substrate 1 made of polyethylene terephthalate, thereby forming leads 2 and 3. Then, conductive carbon paste including a resin binder was printed on the substrate 1, thereby forming a working electrode 4, so as to be in contact with the lead 2.
  • insulating paste was printed on the substrate 1, thereby forming an insulating layer 6.
  • the insulating layer 6 covered the peripheral portion of the working electrode 4, so as to expose a fixed area of the working electrode 4.
  • conductive carbon paste including a resin binder was printed on the substrate 1, thereby forming a ring-shaped counter electrode 5, so as to be in contact with the lead 3.
  • An aqueous solution of 0.5% by weight CMC was dropped on the electrode system 8, that is, the working electrode 4 and the counter electrode 5, and dried, thereby forming a CMC layer.
  • a mixed aqueous solution including PyOx and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7.
  • the contents of PyOx and potassium ferricyanide in the reaction layer 7 were 10 units and 1.3 mg per 1 cm 2 of the reaction layer, respectively.
  • response current values were measured with regard to 180 mg/dl and 360 mg/dl of aqueous glucose solutions also twelve times, respectively in the same manner as described above. The thus obtained response values were found to be increased as the glucose concentration was increased, and the increase ratio was large.
  • a glucose sensor including glucose oxidase (EC1.1.3.4; GOD) instead of PyOx was manufactured, and a response current value was measured twelve times with regard to the glucose solutions having the above-mentioned concentrations.
  • the obtained response current values were fluctuated in the same glucose concentration.
  • the response current values were found to be increased as the glucose concentration was increased, the increase ratio was small.
  • sucrose sensor As an example of the present biosensor, a sucrose sensor was manufactured as follows:
  • an electrode system 8 i.e., a working electrode 4 and a counter electrode 5
  • an insulating layer 6 were formed on an electrically insulating substrate 1 made of polyethylene terephthalate. Then, an aqueous solution of 0.5% by weight CMC was dropped and dried on the electrode system 8, thereby forming a CMC layer.
  • a mixed aqueous solution including PyOx, INV, and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7.
  • the contents of PyOx, INV, and potassium ferricyanide in the reaction layer 7 were 10 units, 40 units and 1.3 mg per 1 cm 2 of the reaction layer, respectively.
  • response current values were measured with regard to 342 mg/dl and 684 mg/dl of aqueous sucrose solutions by using a fresh sucrose sensor in each measurement in the same manner as described above.
  • the obtained response current values were found to be increased as the sucrose concentration was increased, and the increase ratio was large.
  • a maltose sensor and a lactose sensor were manufactured in the same manner except that INV was replaced with maltose hydrolase and lactose hydrolase, respectively. These maltose and lactose sensors exhibited the same effect as described above.
  • a glucose sensor was manufactured as follows:
  • an electrode system 8 i.e., a working electrode 4 and a counter electrode 5
  • an insulating layer 6 were formed on an electrically insulating substrate 1 made of polyethylene terephthalate. Then, an aqueous solution of 0.5% by weight CMC was dropped and dried on the electrode system 8, thereby forming a CMC layer.
  • a mixed aqueous solution including PyOx, GOD, and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7.
  • the contents of PyOx, GOD, and potassium ferricyanide in the reaction layer 7 were 1 unit, 10 units, and 1.3 mg per 1 cm 2 of the reaction layer, respectively.
  • response current values were measured with regard to 180 mg/dl and 360 mg/dl of aqueous glucose solutions by using a fresh glucose sensor in each measurement in the same manner as described above.
  • the response characteristic between glucose concentrations and response current values is shown in FIG. 4 as a curve (a).
  • the glucose sensor including GOD alone as the enzyme exhibited the lowest response current values because the response current values depend upon the concentration of only the ⁇ -glucose included in the sample liquid.
  • the glucose sensor including PyOx alone as the enzyme exhibited higher current values than curve (b) especially when the glucose concentration was low because the response current values depend upon the sum of the concentrations of ⁇ -glucose and ⁇ -glucose included in the sample liquid.
  • the glucose sensor including PyOx alone as the enzyme exhibited lower current values than curve (b) when the glucose concentration was high.
  • the glucose sensor including both PyOx and GOD constantly exhibited high response current values in the widest concentration range.
  • sucrose sensor As an example of the present biosensor, a sucrose sensor was manufactured as follows:
  • an electrode system 8 i.e., a working electrode 4 and a counter electrode 5
  • an insulating layer 6 were formed on an electrically insulating substrate 1 made of polyethylene terephthalate. Then, an aqueous solution of 0.5% by weight CMC was dropped and dried on the electrode system 8, thereby forming a CMC layer.
  • a mixed aqueous solution including PyOx, GOD, INV, and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7.
  • the contents of PyOx, GOD, INV, and potassium ferricyanide in the reaction layer 7 were 1 unit, 10 units, 40 units, and 1.3 mg per 1 cm 2 of the reaction layer 7, respectively.
  • response current values were measured with regard to 342 mg/dl and 684 mg/dl of aqueous sucrose solutions by using a fresh sucrose sensor in each measurement in the same manner as described above.
  • the obtained response current values were found to be increased as the sucrose concentration was increased, and were constantly high in a wide range of the sucrose concentration.
  • a sucrose sensor was manufactured in the same manner as described above except that GOD was excluded from the reaction layer 7, and response current values were similarly measured. The obtained response current values were constantly lower than those obtained by the sucrose sensor including GOD.
  • a maltose sensor and a lactose sensor manufactured by respectively using maltose hydrolase and lactose hydrolase instead of INV were found to exhibit the same effect as described above.
  • a biosensor was manufactured in the same manner as in Examples 1 to 4 except that potassium ferricyanide was not included in the reaction layer 7. Sample liquid having various substrate concentrations as in Examples 1 to 4 were respectively dropped on the electrode system of these biosensors. After a predetermined time, a voltage of +1.0 V on the basis of a voltage at a counter electrode 5 was applied to a working electrode 4, and a current value was measured 5 seconds after the voltage application.
  • the obtained response current values were found to be increased as the concentration of the substrate was increased.
  • a glucose sensor was manufactured in the same manner as in Example 3.
  • response current values were measured with regard to whole blood having glucose concentrations of 170 mg/dl and 320 mg/dl by using a fresh glucose sensor in each measurement in the same manner as described above.
  • the response characteristic between glucose concentrations and response current values is shown as a curve (a) in FIG. 5.
  • the glucose sensor including GOD alone as the enzyme exhibited the lowest response current values because the current values depend upon the concentration of only the ⁇ -glucose in the whole blood.
  • the glucose sensor including PyOx alone as the enzyme exhibited higher response current values than curve (b) because the current values depend upon the sum of the concentrations of ⁇ -glucose and ⁇ -glucose in the whole blood.
  • the glucose sensor including both PyOx and GOD exhibited constantly high response current values in the widest range of the blood glucose concentration.

Abstract

The biosensor of this invention includes an electrically insulating substrate; an electrode system formed on the substrate which includes a working electrode and a counter electrode; and a reaction layer formed on the substrate or above the substrate with a space therebetween. The reaction layer includes a pyranose-oxidizing enzyme.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a biosensor for quantitating a substrate (specific component) contained in a sample liquid such as whole blood, plasma, serum, urine, fruit juice and the like, with accuracy, speed and ease. More particularly, the invention relates to a glucose sensor for electrochemically measuring a concentration of glucose included in a sample liquid by reacting the glucose with an oxidoreductase which can react with specificity to the glucose.
2. Description of the Related Art
Various methods such as an optical rotation method, a colorimetric method, a reductimetry method and other methods which use different kinds of chromatographies have been developed as methods for the quantitative analysis of a saccharide such as sucrose and glucose. However, none of these methods has sufficiently high accuracy because the specificity thereof against saccharides is not very high. Among these methods, the optical rotation method can be easily conducted but is known to be significantly influenced by the operating temperature.
Recently, various types of biosensors have been developed which can easily quantitate a specific component (substrate) in a sample liquid such as a biological sample and food without diluting and stirring the sample liquid.
For example, Japanese Laid-Open Patent Publication No. 3-202764 discloses a biosensor comprising an electrode system formed on an insulating substrate by screen printing or the like and a reaction layer formed on the electrode system and including a hydrophilic polymer, an oxidoreductase, and an electron acceptor. The concentration of a substrate in a sample liquid is measured by using this biosensor as follows. First, the sample liquid is dropped on the reaction layer of the biosensor, so as to dissolve the reaction layer. This causes an enzyme reaction between the substrate in the sample liquid and the oxidoreductase in the reaction layer, and then, the electron acceptor in the reaction layer is reduced. After the completion of the enzyme reaction, the reduced electron acceptor is electrochemically oxidized, thereby measuring the concentration of the substrate in the sample liquid based on an oxidation current value obtained in this oxidation.
U.S. Pat. No. 5,192,415 discloses a biosensor comprising a hydrogen ion concentration control layer which can optimize the pH of the sample liquid depending upon the type of oxidoreductase contained in a reaction layer without previously adjusting the pH of a sample liquid.
U.S. Pat. No. 5,264,103 discloses a biosensor comprising a main electrode system formed on an electrically insulating substrate and including a working electrode and a counter electrode; a reaction layer including an oxidoreductase; and a sub electrode layer provided with an interval from the main electrode system and including a working electrode and a counter electrode.
These biosensors can be used in a wide range of applications, for example as, a glucose sensor, an alcohol sensor, a cholesterol sensor, or an amino acid sensor by appropriately selecting an oxidoreductase to be contained in the reaction layer.
Among these biosensors, a glucose sensor is generally known to include glucose oxidase as the oxidoreductase. Such a glucose sensor has, however, the following problem. Among isomers of glucose, glucose oxidase reacts to β-glucose alone which exists at a proportion of 63% in the equilibrium state. Therefore, a response current value (i.e., detection sensitivity) obtained by such a glucose sensor is so small that measurement error is large, for example, in quantitating an extremely small amount of glucose.
In addition, when this glucose sensor is used to quantitate polysaccharides, most of the glucose produced by a hydrolase is α-glucose, and hence, an additional procedure is required, before the quantitation, for isomerizing α-glucose produced through the hydrolysis into β-glucose by using a mutarotase.
Japanese Patent Application No. 6-291401 (unpublished) relates to a biosensor including both mutarotase and glucose oxidase. In this biosensor, however, the detection sensitivity cannot be sufficiently improved when the total amount of these enzymes is small, and the production cost is increased when the total amount of the enzymes is large. Furthermore, when the concentration of a substrate in a sample liquid is comparatively high, the biosensor including mutarotase and glucose oxidase has lower detection sensitivity as compared with a biosensor excluding mutarotase.
SUMMARY OF THE INVENTION
The biosensor of the present invention comprises an electrically insulating substrate; an electrode system formed on the substrate which includes a working electrode and a counter electrode; and a reaction layer formed on the substrate or above the substrate with a space therebetween. The reaction layer includes a pyranose-oxidizing enzyme.
In one embodiment, the pyranose-oxidizing enzyme is pyranose oxidase (EC1.1.3.10).
In another embodiment, the reaction layer further includes glucose oxidase (EC1.1.3.4).
In still another embodiment, the reaction layer further includes an electron acceptor.
In still another embodiment, the electron acceptor is a ferricyanide ion.
In still another embodiment, the reaction layer further includes polysaccharide hydrolase.
In still another embodiment, the polysaccharide hydrolase is one selected from the group consisting of sucrose hydrolase, maltose hydrolase, and lactose hydrolase.
In one embodiment, the content of the pyranose-oxidizing enzyme is 1 to about 200 units per 1 cm2 of the reaction layer.
In still another embodiment, the content of the pyranose-oxidizing enzyme is about 0.1 to about 200 units per 1 cm2 of the reaction layer.
In still another embodiment, the contents of the pyranose-oxidizing enzyme and the ferricyanide ion are 1 to about 200 units and about 0.21 mg to about 3.30 mg, respectively per 1 cm2 of the reaction layer.
In still another embodiment, the contents of the pyranose-oxidizing enzyme, the glucose oxidase and the ferricyanide ion are about 0.1 to about 200 units, 1 to about 200 units, and about 0.21 mg to about 3.30 mg, respectively per 1 cm2 of the reaction layer.
In one embodiment, the biosensor is used for measuring a blood glucose level.
Alternatively, the biosensor of the present invention, for quantitating a substrate included in a sample liquid by reducing an electron acceptor with an electron generated through an enzyme reaction of the substrate and electrochemically measuring an amount of a reduced form of the electron acceptor, comprises an electrically insulating substrate; an electrode system formed on the substrate and including a working electrode and a counter electrode; and a reaction layer formed on the substrate or above the substrate with a space therebetween. The reaction layer includes a pyranose-oxidizing enzyme and the electron acceptor.
In one embodiment, the reaction layer further includes glucose oxidase (EC1.1.3.4).
In another embodiment, the biosensor is a glucose sensor.
In still another embodiment, the biosensor is used for measuring a blood glucose level.
Thus, the invention described herein makes possible the advantages of (1) providing a biosensor which can measure the concentration of a substrate in a sample liquid with accuracy and speed by simultaneously detecting α-glucose and β-glucose; (2) providing a biosensor which can easily measure the concentration of a substrate in a sample liquid including polysaccharide; and (3) providing a biosensor which can be manufactured at a low cost.
These and other advantages of the present invention will become apparent to those skilled in the art upon reading and understanding the following detailed description with reference to the accompanying figures.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic plane view of a biosensor as an example of the invention in which a reaction layer is omitted;
FIG. 2 is a schematic sectional view of a biosensor as an example of the invention in which a reaction layer is directly disposed on a substrate;
FIG. 3 is a schematic sectional view of a biosensor as another example of the invention in which a reaction layer is disposed above a substrate with a space therebetween;
FIG. 4 is a graph showing the relationship between the concentration of glucose and a response current value obtained by biosensors according to an example and comparative examples of the invention; wherein a curve (a) shows the change of a response current value obtained by using a reaction layer including pyranose oxidase (hereinafter referred to as PyOx) and glucose oxidase (hereinafter referred to as GOD), a curve (b) shows the change of a response current value obtained by using a reaction layer including GOD alone, and a curve (c) shows the change of a response current value obtained by using a reaction layer including PyOx alone; and
FIG. 5 is a graph showing the relationship between the concentration of blood glucose and a response current value obtained by glucose sensors according to an example and comparative examples of the invention; wherein a curve (a) shows the change of a response current value obtained by using a reaction layer including PyOx and GOD, a curve (b) shows the change of a response current value obtained by using a reaction layer including GOD alone as an oxidoreductase, and a curve (c) shows the change of a response current value obtained by using a reaction layer including PyOx alone.
DESCRIPTION OF PREFERRED EMBODIMENTS
A biosensor of this invention comprises an electrically insulating substrate, an electrode system formed on the substrate which includes a working electrode and a counter electrode, and a reaction layer formed either on the substrate or above the substrate with a space therebetween.
The electrically insulating substrate is made from a plate of a synthetic resin such as polyethylene terephthalate, polyethylene, polyester, polypropylene, polystyrene, and polyvinyl chloride.
The electrode system including the working electrode and the counter electrode can be formed on the substrate by a known method. For example, after forming leads on the substrate, the working electrode and the counter electrode are formed so as to be connected to the respective leads and be insulated from each other. The materials for the leads and the electrodes can be any of known conductive materials such as carbon, silver, platinum, gold, and palladium.
The reaction layer used in the present biosensor includes a pyranose-oxidizing enzyme, which can simultaneously oxidize both α-glucose and β-glucose. An example of such a pyranose-oxidizing enzyme includes pyranose oxidase (EC1.1.3.10; PyOx).
The content of PyOx in the reaction layer of the present biosensor is preferably 1 to about 200 units, and more preferably about 2 to about 50 units per 1 cm2 of the reaction layer. The term "unit" herein refers to the amount of an oxidoreductase necessary for oxidizing 1 μmol of glucose or polysaccharide in one minute. When the content of PyOx is smaller than 1 unit per 1 cm2 of the reaction layer, an additional time of several minutes or more is required for the measurement. In addition, due to evaporation of a sample liquid during the additional time, the response current value can be affected. A content of PyOx exceeding about 200 units per 1 cm2 of the reaction layer not only increases the production cost but also causes fluctuation in response current values because the reaction layer can be broken during the formation thereof.
The reaction layer can include glucose oxidase (EC1.1.3.4; GOD), in addition to the pyranose-oxidizing enzyme, in order to further improve the detection sensitivity against glucose in a sample liquid and to enable the glucose sensor to response to a wider range of glucose concentration. The content of GOD is preferably 1 to about 200 units per 1 cm2 of the reaction layer. When GOD is used together with PyOx, the content of PyOx is preferably about 0.1 to about 200 units, and more preferably about 0.2 to about 40 units per 1 cm2 of the reaction layer.
The reaction layer can further include various hydrophilic polymers. Examples of such hydrophilic polymer include carboxy methyl cellulose (hereinafter referred to as CMC), hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), methyl cellulose, ethyl cellulose, ethyl hydroxyethyl cellulose, carboxymethyl ethyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol, polyamino acids such as polylysine, polystyrenesulfonic acid, gelatin or its derivatives, acrylic acid or its salts, methacrylic acid or its salts, starch or its derivatives, and maleic anhydride or its salt. In particular, CMC is preferred.
When a sample liquid including glucose is supplied to the reaction layer of the present biosensor, α-glucose and β-glucose in the sample liquid are respectively oxidized by the pyranose-oxidizing enzyme. Simultaneously, dissolved oxygen in the sample liquid is reduced into hydrogen peroxide. When a voltage is applied at this point, the hydrogen peroxide is oxidized. A response current generated in this oxidation is in proportion to the concentration of the hydrogen peroxide, i.e., the concentration of the substrate in the sample liquid. Thus, the concentration of the substrate in the sample liquid can be obtained by measuring the response current value.
In the present biosensor, the reaction layer can include an electron acceptor so as to form a reduced form of the electron acceptor simultaneously with the enzyme reaction, in stead of producing hydrogen peroxide simultaneously with the oxidation reaction of the substrate. Examples of the electron acceptor include a ferricyanide ion, p-benzoquinone or its derivatives, phenazine methosulfate, Methylene Blue, and ferrocene or its derivative. One or more of the electron acceptor can be used. In particular, a ferricyanide ion is preferred.
The content of the ferricyanide ion is preferably about 0.21 to about 3.30 mg, and more preferably about 0.30 to about 2.59 mg per 1 cm2 of the reaction layer. When the content of the ferricyanide ion is smaller than about 0.21 mg per 1 cm2 of the reaction layer, the measurable range of the glucose concentration can be extremely small. When the content of the ferricyanide ion exceeds about 3.30 mg per 1 cm2 of the reaction layer, fluctuation of response current values can be caused because the reaction layer can be broken during the formation thereof, and the reliability of the biosensor can be degraded while it is stored.
The reaction layer used in the present biosensor can further include a polysaccharide hydrolase for hydrolyzing a polysaccharide to produce α-glucose. The polysaccharide hydrolase is an enzyme capable of hydrolyzing a polysaccharide such as sucrose and maltose to produce glucose. Examples of such polysaccharide hydrolase include sucrose hydrolase such as invertase (hereinafter referred to as INV), maltose hydrolase such as maltase, and lactose hydrolase such as β-galactosidase. The content of the polysaccharide hydrolase is preferably 1 to about 400 units, and more preferably about 2 to about 200 units per 1 cm2 of the reaction layer.
A production method for the present biosensor will now be described referring to FIGS. 1 and 2.
First, a conductive material such as silver paste is printed on an electrically insulating substrate 1 by screen printing, thereby forming leads 2 and 3. Then, another conductive material including a resin binder is printed on the substrate 1, thereby forming a working electrode 4, so as to be in contact with the lead 2.
Then, insulating paste is printed on the substrate 1, thereby forming an insulating layer 6. The insulating layer 6 covers the peripheral portion of the working electrode 4, so as to expose a fixed area of the working electrode 4. As is shown in FIG. 1, the insulating layer 6 also covers part of the leads 2 and 3. Around the working electrode 4 is formed a ring-shaped counter electrode 5 out of a conductive material including a resin binder. The counter electrode 5 is in contact with the lead 3. In this manner, an electrode system 8 including the working electrode 4 and the counter electrode 5 is formed on the substrate 1.
Alternatively, the present biosensor can comprise a three-electrode system formed on the substrate 1 including a reference electrode (not shown) in addition to the working electrode 4 and the counter electrode 5, for the purpose of further stabilizing the measurement accuracy.
A reaction layer is formed on the substrate 1 as follows:
An aqueous solution of the hydrophilic polymer is dropped and dried on the electrode system 8, thereby forming a hydrophilic polymer layer. Then, an aqueous solution including PyOx, and the electron acceptor and/or the polysaccharide hydrolase, if necessary, is dropped and dried on the hydrophilic polymer layer. For repeated application of the present biosensor, the pyranose-oxidizing enzyme, and the polysaccharide hydrolase, if necessary, can be immobilized on the hydrophilic polymer layer through crosslinking with glutaraldehyde or immobilized on the hydrophilic polymer layer together with a polymeric material such as nitrocellulose, cellulose acetate, and polyacrylonitrile. Furthermore, the electron acceptor can be chemically fixed on the hydrophilic polymer layer by using the polymeric material, if necessary. Thus, a reaction layer 7 covering the entire electrode system 8 as shown in FIG. 2 can be formed.
Alternatively, the reaction layer can be disposed above the substrate 1 with a space therebetween. In this case, as is shown in FIG. 3, the biosensor comprises the substrate 1 and a cover 30 disposed above the substrate 1 with a spacer 20 sandwiched therebetween. The cover 30 includes a hole 31 and a reaction layer 37 formed on one surface thereof. The cover 30 is disposed above the substrate 1 so as to oppose the reaction layer 37 and the electrode system 8 to each other. Such a reaction layer 37 disposed above the substrate 1 with a space therebetween can be formed as described in, for example, Japanese Laid-Open Patent Publication No. 1-114747. In this type of biosensor, when a sample liquid supplied through a sample supply port 38 reaches the space between the reaction layer 37 and the electrode system 8, the amount of hydrogen peroxide or a reduced form of the electron acceptor generated in the reaction layer 37 can be measured with the electrode system 8 as in the biosensor shown in FIG. 2.
The present biosensor can be used for quantitating various kinds of substrates included in a biological sample such as whole blood, plasma, serum, and urine, materials of the food industry and product thereof, for example fruit juice. When used for measuring a blood glucose level of a patient in particular, the present biosensor can serve as a disposable blood glucose sensor which can be easily used.
Examples
Specific examples of the present biosensor will now be described. It is noted that the invention is not limited to these examples. In the drawings mentioned in each example, a common reference numeral is used to refer to a common element, and the description is partly omitted for the sake of simplification.
Example 1
As an example of the present biosensor, a glucose sensor was manufactured as follows:
As is shown in FIG. 1, silver paste was printed by screen printing on an electrically insulating substrate 1 made of polyethylene terephthalate, thereby forming leads 2 and 3. Then, conductive carbon paste including a resin binder was printed on the substrate 1, thereby forming a working electrode 4, so as to be in contact with the lead 2.
Next, insulating paste was printed on the substrate 1, thereby forming an insulating layer 6. The insulating layer 6 covered the peripheral portion of the working electrode 4, so as to expose a fixed area of the working electrode 4.
Then, conductive carbon paste including a resin binder was printed on the substrate 1, thereby forming a ring-shaped counter electrode 5, so as to be in contact with the lead 3.
An aqueous solution of 0.5% by weight CMC was dropped on the electrode system 8, that is, the working electrode 4 and the counter electrode 5, and dried, thereby forming a CMC layer. A mixed aqueous solution including PyOx and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7. The contents of PyOx and potassium ferricyanide in the reaction layer 7 were 10 units and 1.3 mg per 1 cm2 of the reaction layer, respectively.
On the reaction layer 7 of the thus manufactured glucose sensor was dropped 90 mg/dl of aqueous glucose solution as a sample liquid. After one minute, a voltage of +0.5 V on the basis of a voltage at the counter electrode 5 was applied to the working electrode 4 and a current value was measured 5 seconds after the voltage application. In this manner, a response current value to the glucose solution was measured twelve times in total by using a fresh glucose sensor in each measurement. Fluctuation in the obtained response current values was small.
Furthermore, response current values were measured with regard to 180 mg/dl and 360 mg/dl of aqueous glucose solutions also twelve times, respectively in the same manner as described above. The thus obtained response values were found to be increased as the glucose concentration was increased, and the increase ratio was large.
As a comparative example, a glucose sensor including glucose oxidase (EC1.1.3.4; GOD) instead of PyOx was manufactured, and a response current value was measured twelve times with regard to the glucose solutions having the above-mentioned concentrations. The obtained response current values were fluctuated in the same glucose concentration. In addition, although the response current values were found to be increased as the glucose concentration was increased, the increase ratio was small.
Example 2
As an example of the present biosensor, a sucrose sensor was manufactured as follows:
In the same manner as in Example 1, leads 2 and 3, an electrode system 8 (i.e., a working electrode 4 and a counter electrode 5), and an insulating layer 6 were formed on an electrically insulating substrate 1 made of polyethylene terephthalate. Then, an aqueous solution of 0.5% by weight CMC was dropped and dried on the electrode system 8, thereby forming a CMC layer.
A mixed aqueous solution including PyOx, INV, and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7. The contents of PyOx, INV, and potassium ferricyanide in the reaction layer 7 were 10 units, 40 units and 1.3 mg per 1 cm2 of the reaction layer, respectively.
When 171 mg/dl of aqueous sucrose solution as a sample liquid was dropped on the reaction layer 7 of the thus manufactured sucrose sensor, the reaction layer 7 was dissolved by the sample liquid. After 3 minutes, a voltage of +0.5 V on the basis of a voltage at the counter electrode 5 was applied to the working electrode 4, and a current value was measured 5 seconds after the voltage application.
Furthermore, response current values were measured with regard to 342 mg/dl and 684 mg/dl of aqueous sucrose solutions by using a fresh sucrose sensor in each measurement in the same manner as described above.
The obtained response current values were found to be increased as the sucrose concentration was increased, and the increase ratio was large.
As comparative examples, a maltose sensor and a lactose sensor were manufactured in the same manner except that INV was replaced with maltose hydrolase and lactose hydrolase, respectively. These maltose and lactose sensors exhibited the same effect as described above.
Example 3
As an example of the present biosensor, a glucose sensor was manufactured as follows:
In the same manner as described in Example 1, leads 2 and 3, an electrode system 8 (i.e., a working electrode 4 and a counter electrode 5), and an insulating layer 6 were formed on an electrically insulating substrate 1 made of polyethylene terephthalate. Then, an aqueous solution of 0.5% by weight CMC was dropped and dried on the electrode system 8, thereby forming a CMC layer.
A mixed aqueous solution including PyOx, GOD, and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7. The contents of PyOx, GOD, and potassium ferricyanide in the reaction layer 7 were 1 unit, 10 units, and 1.3 mg per 1 cm2 of the reaction layer, respectively.
On the reaction layer 7 of the thus manufactured glucose sensor was dropped 90 mg/dl of aqueous glucose solution as a sample liquid. After 1 minute, a voltage of +0.5 V on the basis of a voltage at the counter electrode 5 was applied to the working electrode 4, and a current value was measured 5 seconds after the voltage application.
Furthermore, response current values were measured with regard to 180 mg/dl and 360 mg/dl of aqueous glucose solutions by using a fresh glucose sensor in each measurement in the same manner as described above. The response characteristic between glucose concentrations and response current values is shown in FIG. 4 as a curve (a).
As comparative examples, a glucose sensor not including PyOx and a glucose sensor not including GOD were respectively manufactured, and the response current values were measured in the same manner as described above. The results are shown in FIG. 4 as curves (b) and (c).
As is shown in FIG. 4, the glucose sensor including GOD alone as the enzyme (corresponding to curve (b) in FIG. 4) exhibited the lowest response current values because the response current values depend upon the concentration of only the β-glucose included in the sample liquid. In contrast, the glucose sensor including PyOx alone as the enzyme (corresponding to curve (c) in FIG. 4) exhibited higher current values than curve (b) especially when the glucose concentration was low because the response current values depend upon the sum of the concentrations of α-glucose and β-glucose included in the sample liquid. However, the glucose sensor including PyOx alone as the enzyme exhibited lower current values than curve (b) when the glucose concentration was high. As a result, the glucose sensor including both PyOx and GOD (corresponding to curve (a) in FIG. 4) constantly exhibited high response current values in the widest concentration range.
Example 4
As an example of the present biosensor, a sucrose sensor was manufactured as follows:
In the same manner as in Example 1, leads 2 and 3, an electrode system 8 (i.e., a working electrode 4 and a counter electrode 5), and an insulating layer 6 were formed on an electrically insulating substrate 1 made of polyethylene terephthalate. Then, an aqueous solution of 0.5% by weight CMC was dropped and dried on the electrode system 8, thereby forming a CMC layer.
A mixed aqueous solution including PyOx, GOD, INV, and potassium ferricyanide was dropped and dried on the CMC layer, thereby forming a reaction layer 7. The contents of PyOx, GOD, INV, and potassium ferricyanide in the reaction layer 7 were 1 unit, 10 units, 40 units, and 1.3 mg per 1 cm2 of the reaction layer 7, respectively.
When 171 mg/dl of aqueous sucrose solution was dropped on the reaction layer 7 of the thus manufactured sucrose sensor, the reaction layer 7 was dissolved by the sample liquid. After 3 minutes, a voltage of +0.5 V on the basis of a voltage at the counter electrode 5 was applied to the working electrode 4, and a current value was measured 5 seconds after the voltage application.
Furthermore, response current values were measured with regard to 342 mg/dl and 684 mg/dl of aqueous sucrose solutions by using a fresh sucrose sensor in each measurement in the same manner as described above.
The obtained response current values were found to be increased as the sucrose concentration was increased, and were constantly high in a wide range of the sucrose concentration.
As a comparative example, a sucrose sensor was manufactured in the same manner as described above except that GOD was excluded from the reaction layer 7, and response current values were similarly measured. The obtained response current values were constantly lower than those obtained by the sucrose sensor including GOD.
A maltose sensor and a lactose sensor manufactured by respectively using maltose hydrolase and lactose hydrolase instead of INV were found to exhibit the same effect as described above.
Example 5
A biosensor was manufactured in the same manner as in Examples 1 to 4 except that potassium ferricyanide was not included in the reaction layer 7. Sample liquid having various substrate concentrations as in Examples 1 to 4 were respectively dropped on the electrode system of these biosensors. After a predetermined time, a voltage of +1.0 V on the basis of a voltage at a counter electrode 5 was applied to a working electrode 4, and a current value was measured 5 seconds after the voltage application.
The obtained response current values were found to be increased as the concentration of the substrate was increased.
Example 6
A glucose sensor was manufactured in the same manner as in Example 3.
Whole blood having a glucose concentration of 95 mg/dl was dropped as a sample liquid on a reaction layer 7 of this glucose sensor. After 1 minute, a voltage of +0.5 V on the basis of a voltage at a counter electrode 5 was applied to a working electrode 4, and a current value was measured 5 seconds after the voltage application.
Furthermore, response current values were measured with regard to whole blood having glucose concentrations of 170 mg/dl and 320 mg/dl by using a fresh glucose sensor in each measurement in the same manner as described above. The response characteristic between glucose concentrations and response current values is shown as a curve (a) in FIG. 5.
As comparative examples, a glucose sensor not including PyOx and a glucose sensor not including GOD were respectively manufactured, and response current values were measured in the same manner. The results are shown as curves (b) and (c) in FIG. 5.
As is shown in FIG. 5, the glucose sensor including GOD alone as the enzyme (corresponding to curve (b) in FIG. 5) exhibited the lowest response current values because the current values depend upon the concentration of only the β-glucose in the whole blood. In contrast, the glucose sensor including PyOx alone as the enzyme (corresponding to curve (c) in FIG. 5) exhibited higher response current values than curve (b) because the current values depend upon the sum of the concentrations of α-glucose and β-glucose in the whole blood. As a result, the glucose sensor including both PyOx and GOD (corresponding to curve (a) in FIG. 5) exhibited constantly high response current values in the widest range of the blood glucose concentration.
Various other modifications will be apparent to and can be readily made by those skilled in the art without departing from the scope and spirit of this invention. Accordingly, it is not intended that the scope of the claims appended hereto be limited to the description as set forth herein, but rather that the claims be broadly construed.

Claims (13)

What is claimed is:
1. A biosensor comprising:
an electrically insulating substrate;
an electrode system formed on the substrate which includes a working electrode and a counter electrode; and
a reaction layer formed on the substrate or above the substrate with a space therebetween,
wherein the reaction layer includes a pyranose-oxidizing enzyme and glucose oxidase (EC1.1.3.4).
2. A biosensor according to claim 1, wherein the pyranose-oxidizing enzyme is pyranose oxidase (EC1.1.3.10).
3. A biosensor according to claim 1, wherein the reaction layer further includes an electron acceptor.
4. A biosensor according to claim 3, wherein the electron acceptor is a ferricyanide ion.
5. A biosensor according to claim 4, wherein contents of the pyranose-oxidizing enzyme, the glucose oxidase, and the ferricyanide ion are about 0.1 to about 200 units, 1 to about 200 units, and about 0.21 mg to about 3.30 mg, respectively per 1 cm2 of the reaction layer.
6. A biosensor according to claim 1, wherein the reaction layer further includes a polysaccharide hydrolase.
7. A biosensor according to claim 6, wherein the polysaccharide hydrolase is one selected from the group consisting of sucrose hydrolase, maltose hydrolase, and lactose hydrolase.
8. A biosensor according to claim 1, wherein a content of the pyranose-oxidizing enzyme is 1 to about 200 units per 1 cm2 of the reaction layer.
9. A biosensor according to claim 1, wherein a content of the pyranose-oxidizing enzyme is about 0.1 to about 200 units per 1 cm2 of the reaction layer.
10. A biosensor according to claim 1, wherein the biosensor is used for measuring a blood glucose level.
11. A biosensor for quantitating a biochemical substrate included in a sample liquid by reducing an electron acceptor with an electron generated through an enzyme reaction of the biochemical substrate and electrochemically measuring an amount of a reduced form of the electron acceptor, comprising:
an electrically insulating substrate;
an electrode system formed on the insulating substrate and including a working electrode and a counter electrode; and
a reaction layer formed on the insulating substrate or above the substrate with a space therebetween,
wherein the reaction layer includes a pyranose-oxidizing enzyme, an electron acceptor, and glucose oxidase (EC1.1.3.4).
12. A biosensor according to claim 11, wherein the biosensor is a glucose sensor.
13. A biosensor according to claim 11, wherein the biosensor is used for measuring a blood glucose level.
US08/605,391 1995-02-28 1996-02-22 Biosensor Expired - Lifetime US5651869A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4015795 1995-02-28
JP7-040157 1995-02-28
JP7258595 1995-03-30
JP7-072585 1995-03-30

Publications (1)

Publication Number Publication Date
US5651869A true US5651869A (en) 1997-07-29

Family

ID=26379598

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/605,391 Expired - Lifetime US5651869A (en) 1995-02-28 1996-02-22 Biosensor

Country Status (4)

Country Link
US (1) US5651869A (en)
EP (1) EP0730037B1 (en)
CN (1) CN1098459C (en)
DE (1) DE69617771T2 (en)

Cited By (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906921A (en) * 1997-09-29 1999-05-25 Matsushita Electric Industrial Co., Ltd. Biosensor and method for quantitative measurement of a substrate using the same
US5961799A (en) * 1996-09-03 1999-10-05 Nec Corporation Compact apparatus for measuring a liquid component in a liquid sample
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6120676A (en) 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6162611A (en) 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6232124B1 (en) 1996-05-06 2001-05-15 Verification Technologies, Inc. Automated fingerprint methods and chemistry for product authentication and monitoring
US6251260B1 (en) 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US6258254B1 (en) * 1997-07-28 2001-07-10 Matsushita Electric Industrial Co., Ltd. Biosensor
US6299757B1 (en) 1998-10-08 2001-10-09 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US20020175087A1 (en) * 2000-07-14 2002-11-28 Alastair Hodges Electrochemical method for measuring chemical reaction rates
US6490030B1 (en) 1999-01-18 2002-12-03 Verification Technologies, Inc. Portable product authentication device
US6512580B1 (en) 1999-10-27 2003-01-28 Verification Technologies, Inc. Method and apparatus for portable product authentication
US20030046811A1 (en) * 2001-09-10 2003-03-13 Eumed Biotechnology Co., Ltd. New spacer forming method used for a biosensor
US20030102213A1 (en) * 1997-09-12 2003-06-05 Therasense, Inc. Biosensor
US6583722B2 (en) 2000-12-12 2003-06-24 Kimberly-Clark Worldwide, Inc. Wetness signaling device
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6589626B2 (en) 2000-06-30 2003-07-08 Verification Technologies, Inc. Copy-protected optical media and method of manufacture thereof
US6603403B2 (en) 2000-12-12 2003-08-05 Kimberly-Clark Worldwide, Inc. Remote, wetness signaling system
US6615078B1 (en) 1999-04-22 2003-09-02 Cygnus, Inc. Methods and devices for removing interfering species
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US20030168338A1 (en) * 2001-09-21 2003-09-11 Therasense, Inc. Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
US6638593B2 (en) 2000-06-30 2003-10-28 Verification Technologies, Inc. Copy-protected optical media and method of manufacture thereof
US6654625B1 (en) 1999-06-18 2003-11-25 Therasense, Inc. Mass transport limited in vivo analyte sensor
US20040062759A1 (en) * 1995-07-12 2004-04-01 Cygnus, Inc. Hydrogel formulations for use in electroosmotic extraction and detection of glucose
US20040065562A1 (en) * 2001-10-10 2004-04-08 Alastair Hodges Electrochemical cell
US20040087671A1 (en) * 2002-08-19 2004-05-06 Tamada Janet A. Compositions and methods for enhancement of transdermal analyte flux
US20040178066A1 (en) * 1999-11-15 2004-09-16 Shoji Miyazaki Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US20040206636A1 (en) * 1995-11-16 2004-10-21 Hodges Alastair Mcindoe Electrochemical cell
US20050077176A1 (en) * 1995-06-19 2005-04-14 Lifescan, Inc. Electrochemical cell
US20050173245A1 (en) * 2004-02-09 2005-08-11 Benjamin Feldman Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US20050215871A1 (en) * 2004-02-09 2005-09-29 Feldman Benjamin J Analyte sensor, and associated system and method employing a catalytic agent
US20060175207A1 (en) * 2000-11-30 2006-08-10 Shoji Miyazaki Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US20060205029A1 (en) * 2001-05-16 2006-09-14 Adam Heller Device for the determination of glycated hemoglobin
US20060243288A1 (en) * 2003-01-25 2006-11-02 Tae-Song Kim Method and system for data communication in human body and sensor therefor
US20070289881A1 (en) * 1997-10-16 2007-12-20 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US7368190B2 (en) 2002-05-02 2008-05-06 Abbott Diabetes Care Inc. Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods
US20090255810A1 (en) * 2006-02-27 2009-10-15 Sumitomo Electric Industries, Ltd. Biosensor chip, biosensor system and measuring instrument thereof
US20100021342A1 (en) * 2008-07-22 2010-01-28 Abner David Joseph Method and apparatus for lighted test strip
US7660415B2 (en) 2000-08-03 2010-02-09 Selinfreund Richard H Method and apparatus for controlling access to storage media
US20100089775A1 (en) * 2006-12-19 2010-04-15 Apex Biotechnology Corp. Electrochemical test strip, electrochemical test system, and measurement method using the same
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7811689B2 (en) 1998-06-17 2010-10-12 Abbott Diabetes Care Inc. Biological fuel cell and methods
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
USRE42567E1 (en) 1995-11-16 2011-07-26 Lifescan, Inc. Electrochemical cell
US8029442B2 (en) 2002-11-05 2011-10-04 Abbott Diabetes Care Inc. Sensor inserter assembly
US20110286722A1 (en) * 2003-01-25 2011-11-24 Tae-Song Kim Method and system for data communication using a body
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8116840B2 (en) 2003-10-31 2012-02-14 Abbott Diabetes Care Inc. Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8414749B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9668684B2 (en) 2009-02-26 2017-06-06 Abbott Diabetes Care Inc. Self-powered analyte sensor
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US10028680B2 (en) 2006-04-28 2018-07-24 Abbott Diabetes Care Inc. Introducer assembly and methods of use
US10036709B2 (en) 2014-05-20 2018-07-31 Roche Diabetes Care, Inc. BG meter illuminated test strip
US20180328877A1 (en) * 2017-05-11 2018-11-15 Medtronic Minimed, Inc. Analyte sensors and methods for fabricating analyte sensors
US10194863B2 (en) 2005-09-30 2019-02-05 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
USD961778S1 (en) 2006-02-28 2022-08-23 Abbott Diabetes Care Inc. Analyte sensor device
USD962446S1 (en) 2009-08-31 2022-08-30 Abbott Diabetes Care, Inc. Analyte sensor device
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6059946A (en) * 1997-04-14 2000-05-09 Matsushita Electric Industrial Co., Ltd. Biosensor
CN1067430C (en) * 1997-09-15 2001-06-20 中国科学院长春应用化学研究所 Method for preparing bio-sensor with embedding enzyme of collosol-gel
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
JP3389106B2 (en) 1998-06-11 2003-03-24 松下電器産業株式会社 Electrochemical analysis element
JP3694424B2 (en) * 1998-09-29 2005-09-14 松下電器産業株式会社 Glucose sensor
US6716577B1 (en) 2000-02-02 2004-04-06 Lifescan, Inc. Electrochemical test strip for use in analyte determination
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6572745B2 (en) * 2001-03-23 2003-06-03 Virotek, L.L.C. Electrochemical sensor and method thereof
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
EP1395185B1 (en) 2001-06-12 2010-10-27 Pelikan Technologies Inc. Electric lancet actuator
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
ES2357887T3 (en) 2001-06-12 2011-05-03 Pelikan Technologies Inc. APPARATUS FOR IMPROVING THE BLOOD OBTAINING SUCCESS RATE FROM A CAPILLARY PUNCTURE.
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
CA2494250C (en) * 2002-08-13 2009-02-10 Gunze Limited Biosensor and method for manufacturing same
CN100389322C (en) * 2002-11-27 2008-05-21 中资汉脉(北京)生物技术有限公司 Nano silicon membrane biological sensor
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP1628567B1 (en) 2003-05-30 2010-08-04 Pelikan Technologies Inc. Method and apparatus for fluid injection
ES2490740T3 (en) 2003-06-06 2014-09-04 Sanofi-Aventis Deutschland Gmbh Apparatus for blood fluid sampling and analyte detection
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
JP4700687B2 (en) * 2005-03-29 2011-06-15 シーシーアイ株式会社 Biosensor
CN100403018C (en) * 2006-01-20 2008-07-16 南京剑桥医疗器械有限公司 Siphon nano-biosensing chip and preparing method thereof
BG1039U1 (en) * 2007-04-25 2008-04-30 Павлинка КАЦАРОВА Biosensor transducer
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8894262B2 (en) 2013-03-11 2014-11-25 Roche Diagnostic Operations, Inc. Blood glucose test strip illumination device and method
TWM467058U (en) * 2013-05-10 2013-12-01 Rapha Bio Ltd Biochemical sensor

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62114747A (en) * 1985-11-15 1987-05-26 O C C:Kk Continuous casting method for metallic bar
JPS63294799A (en) * 1987-05-27 1988-12-01 Nippon Kayaku Co Ltd Method for simultaneously measuring glucose and 1,5-anhydroglycitol
JPS6459056A (en) * 1987-08-28 1989-03-06 Matsushita Electric Ind Co Ltd Biosensor
JPH0262958A (en) * 1988-08-30 1990-03-02 Kanzaki Paper Mfg Co Ltd Method of measuring concentration of phosphoric acid
JPH03202764A (en) * 1989-09-21 1991-09-04 Matsushita Electric Ind Co Ltd Biosensor and manufacture thereof
US5081037A (en) * 1988-03-15 1992-01-14 Kanzaki Paper Mfg. Co., Ltd. Enzyme electrode for measuring malto-oligosaccharide
US5192416A (en) * 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
JPH05196595A (en) * 1992-01-21 1993-08-06 Matsushita Electric Ind Co Ltd Manufacture of glucose sensor
US5264103A (en) * 1991-10-18 1993-11-23 Matsushita Electric Industrial Co., Ltd. Biosensor and a method for measuring a concentration of a substrate in a sample

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62114747A (en) * 1985-11-15 1987-05-26 O C C:Kk Continuous casting method for metallic bar
JPS63294799A (en) * 1987-05-27 1988-12-01 Nippon Kayaku Co Ltd Method for simultaneously measuring glucose and 1,5-anhydroglycitol
JPS6459056A (en) * 1987-08-28 1989-03-06 Matsushita Electric Ind Co Ltd Biosensor
US5081037A (en) * 1988-03-15 1992-01-14 Kanzaki Paper Mfg. Co., Ltd. Enzyme electrode for measuring malto-oligosaccharide
JPH0262958A (en) * 1988-08-30 1990-03-02 Kanzaki Paper Mfg Co Ltd Method of measuring concentration of phosphoric acid
JPH03202764A (en) * 1989-09-21 1991-09-04 Matsushita Electric Ind Co Ltd Biosensor and manufacture thereof
US5192416A (en) * 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
US5264103A (en) * 1991-10-18 1993-11-23 Matsushita Electric Industrial Co., Ltd. Biosensor and a method for measuring a concentration of a substrate in a sample
JPH05196595A (en) * 1992-01-21 1993-08-06 Matsushita Electric Ind Co Ltd Manufacture of glucose sensor

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Abstract of JP 01114747 (Matsushita Electric) Oct. 29, 1987. *
Abstract of JP 02062958 (Karigome et al.) Mar. 2, 1990. *
Abstract of JP 05196595 (Yoshinobu Tokundo) Aug. 6, 1993. *
Abstract of JP 6459056 (Shigeo Kobayashi) Mar. 6, 1989. *
Chemical Abstracts, vol. III, No. 25, Dec. 18, 1989, Columbus, Ohio, USA, S. Tajima et al, "Simultaneous Determination of Glucose and 1,5-any-Droglucitrol" p. 394, No. 228, 556 J; & JPN, Kokai Koha, 1988 No month available.
Chemical Abstracts, vol. III, No. 25, Dec. 18, 1989, Columbus, Ohio, USA, S. Tajima et al, Simultaneous Determination of Glucose and 1,5 any Droglucitrol p. 394, No. 228, 556 J; & JPN, Kokai Koha, 1988 No month available. *
JP A 63 294 799 (88 294799). *
JP-A-63-294 799 (88 294799).
Search Report for European Patent Application No. 96102861.0 dated Sep. 5, 1996. *

Cited By (494)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741590B2 (en) 1991-03-04 2014-06-03 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8414749B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8588881B2 (en) 1991-03-04 2013-11-19 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8414750B2 (en) 1991-03-04 2013-04-09 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US6514718B2 (en) 1991-03-04 2003-02-04 Therasense, Inc. Subcutaneous glucose electrode
US6284478B1 (en) 1993-12-02 2001-09-04 E. Heller & Company Subcutaneous glucose electrode
US6162611A (en) 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US6329161B1 (en) 1993-12-02 2001-12-11 Therasense, Inc. Subcutaneous glucose electrode
USRE44330E1 (en) 1995-06-19 2013-07-02 Lifescan Inc. Electrochemical cell
US20100078324A1 (en) * 1995-06-19 2010-04-01 Lifescan, Inc. Electrochemical cell
US20050077176A1 (en) * 1995-06-19 2005-04-14 Lifescan, Inc. Electrochemical cell
US20100192369A1 (en) * 1995-06-19 2010-08-05 Lifescan, Inc. Electrochemical Cell
US20100084288A1 (en) * 1995-06-19 2010-04-08 Lifescan, Inc. Electrochemical Cell
US8597480B2 (en) 1995-06-19 2013-12-03 Lifescan, Inc. Electrochemical cell
US8075760B2 (en) 1995-06-19 2011-12-13 Lifescan, Inc. Electrochemical cell
US8101056B2 (en) 1995-06-19 2012-01-24 Lifescan, Inc. Electrochemical cell
US7608175B2 (en) 1995-06-19 2009-10-27 Lifescan, Inc. Electrochemical cell
US7604722B2 (en) 1995-06-19 2009-10-20 Lifescan, Inc. Electrochemical cell
US20040062759A1 (en) * 1995-07-12 2004-04-01 Cygnus, Inc. Hydrogel formulations for use in electroosmotic extraction and detection of glucose
US7431814B2 (en) 1995-11-16 2008-10-07 Lifescan, Inc. Electrochemical cell
US20060254932A1 (en) * 1995-11-16 2006-11-16 Lifescan, Inc. Electrochemical cell
US20040206636A1 (en) * 1995-11-16 2004-10-21 Hodges Alastair Mcindoe Electrochemical cell
USRE42567E1 (en) 1995-11-16 2011-07-26 Lifescan, Inc. Electrochemical cell
US6458595B1 (en) 1996-05-06 2002-10-01 Verification Technologies, Inc. Automated fingerprint methods and chemistry for product authentication and monitoring
US6232124B1 (en) 1996-05-06 2001-05-15 Verification Technologies, Inc. Automated fingerprint methods and chemistry for product authentication and monitoring
US9075004B2 (en) 1996-06-19 2015-07-07 Lifescan, Inc. Electrochemical cell
US5961799A (en) * 1996-09-03 1999-10-05 Nec Corporation Compact apparatus for measuring a liquid component in a liquid sample
US8105476B2 (en) 1997-02-06 2012-01-31 Abbott Diabetes Care Inc. Integrated lancing and measurement device
US6143164A (en) 1997-02-06 2000-11-07 E. Heller & Company Small volume in vitro analyte sensor
US6120676A (en) 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US7909984B2 (en) 1997-02-06 2011-03-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US7906009B2 (en) 1997-02-06 2011-03-15 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6576101B1 (en) 1997-02-06 2003-06-10 Therasense, Inc. Small volume in vitro analyte sensor
US7988845B2 (en) 1997-02-06 2011-08-02 Abbott Diabetes Care Inc. Integrated lancing and measurement device and analyte measuring methods
US8808531B2 (en) 1997-02-06 2014-08-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6551494B1 (en) 1997-02-06 2003-04-22 Therasense, Inc. Small volume in vitro analyte sensor
US9234864B2 (en) 1997-02-06 2016-01-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8142642B2 (en) 1997-02-06 2012-03-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8114270B2 (en) 1997-02-06 2012-02-14 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8114271B2 (en) 1997-02-06 2012-02-14 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US20040055898A1 (en) * 1997-02-06 2004-03-25 Adam Heller Integrated lancing and measurement device and analyte measuring methods
US8118992B2 (en) 1997-02-06 2012-02-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US7335294B2 (en) 1997-02-06 2008-02-26 Abbott Diabetes Care, Inc. Integrated lancing and measurement device and analyte measuring methods
US20080017522A1 (en) * 1997-02-06 2008-01-24 Therasense, Inc. Integrated Lancing and Measurement Device
US8142643B2 (en) 1997-02-06 2012-03-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8123929B2 (en) 1997-02-06 2012-02-28 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6258254B1 (en) * 1997-07-28 2001-07-10 Matsushita Electric Industrial Co., Ltd. Biosensor
US7901554B2 (en) 1997-09-12 2011-03-08 Abbott Diabetes Care Inc. Biosensor
US7713406B2 (en) 1997-09-12 2010-05-11 Abbott Diabetes Care Inc. Biosensor
US6893545B2 (en) 1997-09-12 2005-05-17 Therasense, Inc. Biosensor
US7905998B2 (en) 1997-09-12 2011-03-15 Abbott Diabetes Care Inc. Biosensor
US20080257728A1 (en) * 1997-09-12 2008-10-23 Therasense, Inc. Biosensor
US7918988B2 (en) 1997-09-12 2011-04-05 Abbott Diabetes Care Inc. Biosensor
US8414761B2 (en) 1997-09-12 2013-04-09 Abbott Diabetes Care Inc. Biosensor
US20050258052A1 (en) * 1997-09-12 2005-11-24 Therasense, Inc. Biosensor
US8557103B2 (en) 1997-09-12 2013-10-15 Abbott Diabetes Care Inc. Biosensor
US20030102213A1 (en) * 1997-09-12 2003-06-05 Therasense, Inc. Biosensor
US7998336B2 (en) 1997-09-12 2011-08-16 Abbott Diabetes Care Inc. Biosensor
US5906921A (en) * 1997-09-29 1999-05-25 Matsushita Electric Industrial Co., Ltd. Biosensor and method for quantitative measurement of a substrate using the same
US7998337B2 (en) 1997-10-16 2011-08-16 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US8221612B2 (en) * 1997-10-16 2012-07-17 Abbott Diabetes Care Inc. Biosensor electrode mediators for regeneration of cofactors
US20090166223A1 (en) * 1997-10-16 2009-07-02 Forrow Nigel J Biosensor electrode mediators for regeneration of cofactors
US20090090625A1 (en) * 1997-10-16 2009-04-09 Forrow Nigel J Biosensor electrode mediators for regeneration of cofactors
US8012341B2 (en) 1997-10-16 2011-09-06 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US20090090624A1 (en) * 1997-10-16 2009-04-09 Forrow Nigel J Biosensor electrode mediators for regeneration of cofactors
US20070289881A1 (en) * 1997-10-16 2007-12-20 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US8241485B2 (en) 1997-10-16 2012-08-14 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US8168051B2 (en) 1998-03-04 2012-05-01 Abbott Diabetes Care Inc. Sensor for determination of glucose
US8117734B2 (en) 1998-03-04 2012-02-21 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US7996054B2 (en) 1998-03-04 2011-08-09 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8706180B2 (en) 1998-03-04 2014-04-22 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8136220B2 (en) 1998-03-04 2012-03-20 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US8463351B2 (en) 1998-03-04 2013-06-11 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8273227B2 (en) 1998-03-04 2012-09-25 Abbott Diabetes Care Inc. Sensor for in vitro determination of glucose
US6484046B1 (en) 1998-03-04 2002-11-19 Therasense, Inc. Electrochemical analyte sensor
US7879213B2 (en) 1998-03-04 2011-02-01 Abbott Diabetes Care Inc. Sensor for in vitro determination of glucose
US7861397B2 (en) 1998-03-04 2011-01-04 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US7721412B2 (en) 1998-03-04 2010-05-25 Abbott Diabetes Care Inc. Method of making an electrochemical sensor
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6565509B1 (en) 1998-04-30 2003-05-20 Therasense, Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8679688B2 (en) 1998-06-17 2014-03-25 Abbott Diabetes Care In. Biological fuel cell and methods
US8241797B2 (en) 1998-06-17 2012-08-14 Abbott Diabetes Care Inc. Biological fuel cell and methods
US7998625B2 (en) 1998-06-17 2011-08-16 Abbott Diabetes Care Inc. Biological fuel cell and methods
US7998624B2 (en) 1998-06-17 2011-08-16 Abbott Diabetes Care Inc. Biological fuel cell and methods
US9070934B2 (en) 1998-06-17 2015-06-30 Abbott Diabetes Care Inc. Biological fuel cell and methods
US8889305B2 (en) 1998-06-17 2014-11-18 Abbott Diabetes Care Inc. Biological fuel cell and methods
US9509010B2 (en) 1998-06-17 2016-11-29 Abbott Diabetes Care Inc. Biological fuel cell and methods
US20110117452A1 (en) * 1998-06-17 2011-05-19 Abbott Diabetes Care Inc. Biological Fuel Cell and Methods
USRE45370E1 (en) 1998-06-17 2015-02-10 Abbott Diabetes Care Inc. Biological fuel cell and methods
US20110117451A1 (en) * 1998-06-17 2011-05-19 Abbott Diabetes Care Inc. Biological Fuel Cell and Methods
US8435682B2 (en) 1998-06-17 2013-05-07 Abbott Diabetes Care Inc. Biological fuel cell and methods
US7811689B2 (en) 1998-06-17 2010-10-12 Abbott Diabetes Care Inc. Biological fuel cell and methods
US20110053005A1 (en) * 1998-06-17 2011-03-03 Abbott Diabetes Care Inc. Biological Fuel Cell and Methods
US6251260B1 (en) 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US9234863B2 (en) 1998-10-08 2016-01-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8083929B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8425743B2 (en) 1998-10-08 2013-04-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8163164B2 (en) 1998-10-08 2012-04-24 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8701282B2 (en) 1998-10-08 2014-04-22 Abbott Diabetes Care Inc. Method for manufacturing a biosensor
US9891185B2 (en) 1998-10-08 2018-02-13 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8728297B2 (en) 1998-10-08 2014-05-20 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8425758B2 (en) 1998-10-08 2013-04-23 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US6299757B1 (en) 1998-10-08 2001-10-09 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US8182671B2 (en) 1998-10-08 2012-05-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8182670B2 (en) 1998-10-08 2012-05-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8186044B2 (en) 1998-10-08 2012-05-29 Abbott Diabetes Care Inc. Method of manufacturing small volume in vitro analyte sensors
US8118993B2 (en) 1998-10-08 2012-02-21 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8187895B2 (en) 1998-10-08 2012-05-29 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8192611B2 (en) 1998-10-08 2012-06-05 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US8211363B2 (en) 1998-10-08 2012-07-03 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US6461496B1 (en) 1998-10-08 2002-10-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US8449758B2 (en) 1998-10-08 2013-05-28 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8221685B2 (en) 1998-10-08 2012-07-17 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US9341591B2 (en) 1998-10-08 2016-05-17 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US8091220B2 (en) 1998-10-08 2012-01-10 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US8087162B2 (en) 1998-10-08 2012-01-03 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US8226815B2 (en) 1998-10-08 2012-07-24 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8083928B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8153063B2 (en) 1998-10-08 2012-04-10 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8083924B2 (en) 1998-10-08 2011-12-27 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8377378B2 (en) 1998-10-08 2013-02-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US9316609B2 (en) 1998-10-08 2016-04-19 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6618934B1 (en) 1998-10-08 2003-09-16 Therasense, Inc. Method of manufacturing small volume in vitro analyte sensor
US8650751B2 (en) 1998-10-08 2014-02-18 Abbott Diabetes Care Inc. Methods of making small volume in vitro analyte sensors
US6592745B1 (en) 1998-10-08 2003-07-15 Therasense, Inc. Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US8272125B2 (en) 1998-10-08 2012-09-25 Abbott Diabetes Care Inc. Method of manufacturing in vitro analyte sensors
US8262996B2 (en) 1998-10-08 2012-09-11 Abbott Diabetes Care Inc. Small volume in vitro sensor and methods of making
US8268163B2 (en) 1998-10-08 2012-09-18 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8268144B2 (en) 1998-10-08 2012-09-18 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8372261B2 (en) 1998-10-08 2013-02-12 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US8273241B2 (en) 1998-10-08 2012-09-25 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor and methods of making
US9291592B2 (en) 1998-10-08 2016-03-22 Abbott Diabetes Care Inc. Small volume in vitro analyte sensor
US6707539B2 (en) 1999-01-18 2004-03-16 Verification Technologies, Inc. Portable product authentication device
US6490030B1 (en) 1999-01-18 2002-12-03 Verification Technologies, Inc. Portable product authentication device
US6902905B2 (en) 1999-04-22 2005-06-07 Cygnus, Inc. Glucose measuring assembly with a hydrogel
US7183068B2 (en) 1999-04-22 2007-02-27 Animas Technologies, Llc Methods of manufacturing glucose measuring assemblies with hydrogels
US6615078B1 (en) 1999-04-22 2003-09-02 Cygnus, Inc. Methods and devices for removing interfering species
US20050170448A1 (en) * 1999-04-22 2005-08-04 Cygnus, Inc. Methods of manufacturing glucose measuring assemblies with hydrogels
US20030199745A1 (en) * 1999-04-22 2003-10-23 Cygnus, Inc. Methods and devices for removing interfering species
US6654625B1 (en) 1999-06-18 2003-11-25 Therasense, Inc. Mass transport limited in vivo analyte sensor
US6512580B1 (en) 1999-10-27 2003-01-28 Verification Technologies, Inc. Method and apparatus for portable product authentication
US6749740B2 (en) 1999-11-04 2004-06-15 Therasense, Inc. Small volume in vitro analyte sensor and methods
US8066858B2 (en) 1999-11-04 2011-11-29 Abbott Diabetes Care Inc. Analyte sensor with insertion monitor, and methods
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US20090152111A1 (en) * 1999-11-15 2009-06-18 Shoji Miyazaki Biosensor, thin film electrode forming method, quantification apparatus, and quantificaion method
US8475646B2 (en) 1999-11-15 2013-07-02 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8470162B2 (en) 1999-11-15 2013-06-25 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8480878B2 (en) 1999-11-15 2013-07-09 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8980074B2 (en) 1999-11-15 2015-03-17 Panasonic Healthcare Holdings Co., Ltd. Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8480866B2 (en) 1999-11-15 2013-07-09 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8480867B2 (en) 1999-11-15 2013-07-09 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US20110117269A1 (en) * 1999-11-15 2011-05-19 Shoji Miyazaki Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8025780B2 (en) 1999-11-15 2011-09-27 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US7998325B2 (en) 1999-11-15 2011-08-16 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8741124B2 (en) 1999-11-15 2014-06-03 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US20040178066A1 (en) * 1999-11-15 2004-09-16 Shoji Miyazaki Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US20110174613A1 (en) * 1999-11-15 2011-07-21 Shoji Miyazaki Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US20110147234A1 (en) * 1999-11-15 2011-06-23 Shoji Miyazaki Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8349157B2 (en) 1999-11-15 2013-01-08 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8142629B2 (en) 1999-11-15 2012-03-27 Panasonic Corporation Biosensor, thin film electrode forming method, quantification apparatus, and quantification method
US8795176B2 (en) 2000-06-27 2014-08-05 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement device
US9271669B2 (en) 2000-06-27 2016-03-01 Abbott Diabetes Care Inc. Method for integrated sample acquisition and analyte measurement device
US8532731B2 (en) 2000-06-27 2013-09-10 Abbott Diabetes Care Inc. Methods of determining analyte concentration
US9017259B2 (en) 2000-06-27 2015-04-28 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement device
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US9662057B2 (en) 2000-06-27 2017-05-30 Abbott Diabetes Care Inc. Integrated sample acquisition and analyte measurement method
US6638593B2 (en) 2000-06-30 2003-10-28 Verification Technologies, Inc. Copy-protected optical media and method of manufacture thereof
US6589626B2 (en) 2000-06-30 2003-07-08 Verification Technologies, Inc. Copy-protected optical media and method of manufacture thereof
US7022217B2 (en) 2000-07-14 2006-04-04 Lifescan, Inc. Electrochemical method for measuring chemical reaction rates
US20020175087A1 (en) * 2000-07-14 2002-11-28 Alastair Hodges Electrochemical method for measuring chemical reaction rates
US7660415B2 (en) 2000-08-03 2010-02-09 Selinfreund Richard H Method and apparatus for controlling access to storage media
US7850839B2 (en) 2000-11-30 2010-12-14 Panasonic Corporation Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US9797858B2 (en) 2000-11-30 2017-10-24 Panasonic Healthcare Holdings Co., Ltd. Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US8298400B2 (en) 2000-11-30 2012-10-30 Panasonic Corporation Method of measuring quantity of substrate
US8097147B2 (en) 2000-11-30 2012-01-17 Panasonic Corporation Method of measuring quantity of substrate
US8668820B2 (en) 2000-11-30 2014-03-11 Panasonic Corporation Method of measuring quantity of substrate
US20110132777A1 (en) * 2000-11-30 2011-06-09 Shoji Miyazaki Method of measuring quantity of substrate
US8771487B2 (en) 2000-11-30 2014-07-08 Panasonic Corporation Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US20110132776A1 (en) * 2000-11-30 2011-06-09 Shoji Miyazaki Method of measuring quantity of substrate
US20100320097A1 (en) * 2000-11-30 2010-12-23 Shoji Miyazaki Method of measuring quantity of substrate
US20060175207A1 (en) * 2000-11-30 2006-08-10 Shoji Miyazaki Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US8101063B2 (en) 2000-11-30 2012-01-24 Panasonic Corporation Method of measuring quantity of substrate
US20080110754A1 (en) * 2000-11-30 2008-05-15 Shoji Miyazaki Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US10605757B2 (en) 2000-11-30 2020-03-31 Phc Holdings Corporation Biosensor, measuring instrument for biosensor, and method of quantifying substrate
US6603403B2 (en) 2000-12-12 2003-08-05 Kimberly-Clark Worldwide, Inc. Remote, wetness signaling system
US6583722B2 (en) 2000-12-12 2003-06-24 Kimberly-Clark Worldwide, Inc. Wetness signaling device
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8236242B2 (en) 2001-04-02 2012-08-07 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US8268243B2 (en) 2001-04-02 2012-09-18 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8765059B2 (en) 2001-04-02 2014-07-01 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US20060205029A1 (en) * 2001-05-16 2006-09-14 Adam Heller Device for the determination of glycated hemoglobin
US8460525B2 (en) 2001-05-16 2013-06-11 Abbott Diabetes Care Inc. Device for the determination of glycated hemoglobin
US8206563B2 (en) 2001-05-16 2012-06-26 Abbott Diabetes Care Inc. Device for the determination of glycated hemoglobin
US6787013B2 (en) 2001-09-10 2004-09-07 Eumed Biotechnology Co., Ltd. Biosensor
US20030046811A1 (en) * 2001-09-10 2003-03-13 Eumed Biotechnology Co., Ltd. New spacer forming method used for a biosensor
US7052591B2 (en) 2001-09-21 2006-05-30 Therasense, Inc. Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
US20030168338A1 (en) * 2001-09-21 2003-09-11 Therasense, Inc. Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
US20040065562A1 (en) * 2001-10-10 2004-04-08 Alastair Hodges Electrochemical cell
US8801907B2 (en) 2001-10-10 2014-08-12 Lifescan, Inc. Electrochemical cell
US7431820B2 (en) 2001-10-10 2008-10-07 Lifescan, Inc. Electrochemical cell
US8486243B2 (en) 2001-10-10 2013-07-16 Lifescan, Inc. Electrochemical cell
US8759055B2 (en) 2002-05-02 2014-06-24 Abbott Diabetes Care Inc. Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods
US7368190B2 (en) 2002-05-02 2008-05-06 Abbott Diabetes Care Inc. Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods
US20040087671A1 (en) * 2002-08-19 2004-05-06 Tamada Janet A. Compositions and methods for enhancement of transdermal analyte flux
US7150975B2 (en) 2002-08-19 2006-12-19 Animas Technologies, Llc Hydrogel composition for measuring glucose flux
US20060105420A1 (en) * 2002-08-19 2006-05-18 Tamada Janet A Compositions and methods for enhancement of transdermal analyte flux
US10973443B2 (en) 2002-11-05 2021-04-13 Abbott Diabetes Care Inc. Sensor inserter assembly
US8029442B2 (en) 2002-11-05 2011-10-04 Abbott Diabetes Care Inc. Sensor inserter assembly
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
US11141084B2 (en) 2002-11-05 2021-10-12 Abbott Diabetes Care Inc. Sensor inserter assembly
US11116430B2 (en) 2002-11-05 2021-09-14 Abbott Diabetes Care Inc. Sensor inserter assembly
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8187183B2 (en) 2002-12-31 2012-05-29 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10039881B2 (en) 2002-12-31 2018-08-07 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8622903B2 (en) 2002-12-31 2014-01-07 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US20060243288A1 (en) * 2003-01-25 2006-11-02 Tae-Song Kim Method and system for data communication in human body and sensor therefor
US20110286722A1 (en) * 2003-01-25 2011-11-24 Tae-Song Kim Method and system for data communication using a body
US8160672B2 (en) * 2003-01-25 2012-04-17 Korea Institute Of Science And Technology Method and system for data communication in human body and sensor therefor
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8647269B2 (en) 2003-06-10 2014-02-11 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8219175B2 (en) 2003-10-31 2012-07-10 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8116840B2 (en) 2003-10-31 2012-02-14 Abbott Diabetes Care Inc. Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US8684930B2 (en) 2003-10-31 2014-04-01 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8219174B2 (en) 2003-10-31 2012-07-10 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US20050215871A1 (en) * 2004-02-09 2005-09-29 Feldman Benjamin J Analyte sensor, and associated system and method employing a catalytic agent
US20070191701A1 (en) * 2004-02-09 2007-08-16 Abbott Diabetes Care, Inc. Analyte Sensor, and Associated System and Method Employing a Catalytic Agent
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8761857B2 (en) 2004-02-09 2014-06-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US20050173245A1 (en) * 2004-02-09 2005-08-11 Benjamin Feldman Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US11160475B2 (en) 2004-12-29 2021-11-02 Abbott Diabetes Care Inc. Sensor inserter having introducer
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11457869B2 (en) 2005-09-30 2022-10-04 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10194863B2 (en) 2005-09-30 2019-02-05 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9775563B2 (en) 2005-09-30 2017-10-03 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
USD979766S1 (en) 2005-09-30 2023-02-28 Abbott Diabetes Care Inc. Analyte sensor device
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US10342489B2 (en) 2005-09-30 2019-07-09 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9480421B2 (en) 2005-09-30 2016-11-01 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9332933B2 (en) 2005-12-28 2016-05-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US10307091B2 (en) 2005-12-28 2019-06-04 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US20090255810A1 (en) * 2006-02-27 2009-10-15 Sumitomo Electric Industries, Ltd. Biosensor chip, biosensor system and measuring instrument thereof
US8012321B2 (en) * 2006-02-27 2011-09-06 Sumitomo Electric Industries, Ltd. Biosensor chip, biosensor system and measuring instrument thereof
US10117614B2 (en) 2006-02-28 2018-11-06 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US8506482B2 (en) 2006-02-28 2013-08-13 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US11872039B2 (en) 2006-02-28 2024-01-16 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
USD961778S1 (en) 2006-02-28 2022-08-23 Abbott Diabetes Care Inc. Analyte sensor device
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US10028680B2 (en) 2006-04-28 2018-07-24 Abbott Diabetes Care Inc. Introducer assembly and methods of use
US10736547B2 (en) 2006-04-28 2020-08-11 Abbott Diabetes Care Inc. Introducer assembly and methods of use
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US8862198B2 (en) 2006-09-10 2014-10-14 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9808186B2 (en) 2006-09-10 2017-11-07 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US10362972B2 (en) 2006-09-10 2019-07-30 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US11724029B2 (en) 2006-10-23 2023-08-15 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US11234621B2 (en) 2006-10-23 2022-02-01 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US10070810B2 (en) 2006-10-23 2018-09-11 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US10363363B2 (en) 2006-10-23 2019-07-30 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US20100089775A1 (en) * 2006-12-19 2010-04-15 Apex Biotechnology Corp. Electrochemical test strip, electrochemical test system, and measurement method using the same
US8409424B2 (en) * 2006-12-19 2013-04-02 Apex Biotechnology Corp. Electrochemical test strip, electrochemical test system, and measurement method using the same
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10952611B2 (en) 2007-05-08 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US11696684B2 (en) 2007-05-08 2023-07-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10653317B2 (en) 2007-05-08 2020-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8765482B2 (en) 2008-07-22 2014-07-01 Roche Diagnostics Operations, Inc. Method and apparatus for lighted test strip
US8465977B2 (en) 2008-07-22 2013-06-18 Roche Diagnostics Operations, Inc. Method and apparatus for lighted test strip
US20100021342A1 (en) * 2008-07-22 2010-01-28 Abner David Joseph Method and apparatus for lighted test strip
US8676513B2 (en) 2009-01-29 2014-03-18 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9066709B2 (en) 2009-01-29 2015-06-30 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8473220B2 (en) 2009-01-29 2013-06-25 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
USD957642S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor inserter
US10786190B2 (en) 2009-02-03 2020-09-29 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD957643S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor device
US9636068B2 (en) 2009-02-03 2017-05-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD882432S1 (en) 2009-02-03 2020-04-28 Abbott Diabetes Care Inc. Analyte sensor on body unit
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD955599S1 (en) 2009-02-03 2022-06-21 Abbott Diabetes Care Inc. Analyte sensor inserter
US9993188B2 (en) 2009-02-03 2018-06-12 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US10631768B2 (en) 2009-02-26 2020-04-28 Abbott Diabetes Inc. Self-powered analyte sensor
US9668684B2 (en) 2009-02-26 2017-06-06 Abbott Diabetes Care Inc. Self-powered analyte sensor
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US11045147B2 (en) 2009-08-31 2021-06-29 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
USD962446S1 (en) 2009-08-31 2022-08-30 Abbott Diabetes Care, Inc. Analyte sensor device
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750439B2 (en) 2009-09-29 2017-09-05 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750444B2 (en) 2009-09-30 2017-09-05 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US10765351B2 (en) 2009-09-30 2020-09-08 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US11259725B2 (en) 2009-09-30 2022-03-01 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US11000216B2 (en) 2010-03-24 2021-05-11 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD948722S1 (en) 2010-03-24 2022-04-12 Abbott Diabetes Care Inc. Analyte sensor inserter
US10010280B2 (en) 2010-03-24 2018-07-03 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11013440B2 (en) 2010-03-24 2021-05-25 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD997362S1 (en) 2010-03-24 2023-08-29 Abbott Diabetes Care Inc. Analyte sensor inserter
USD987830S1 (en) 2010-03-24 2023-05-30 Abbott Diabetes Care Inc. Analyte sensor inserter
US9687183B2 (en) 2010-03-24 2017-06-27 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11058334B1 (en) 2010-03-24 2021-07-13 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10292632B2 (en) 2010-03-24 2019-05-21 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11064922B1 (en) 2010-03-24 2021-07-20 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10772547B1 (en) 2010-03-24 2020-09-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9265453B2 (en) 2010-03-24 2016-02-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9186098B2 (en) 2010-03-24 2015-11-17 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10959654B2 (en) 2010-03-24 2021-03-30 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10952657B2 (en) 2010-03-24 2021-03-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10945649B2 (en) 2010-03-24 2021-03-16 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881341B1 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11266335B2 (en) 2010-03-24 2022-03-08 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881340B2 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11246519B2 (en) 2010-03-24 2022-02-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9215992B2 (en) 2010-03-24 2015-12-22 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10959653B2 (en) 2010-06-29 2021-03-30 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10973449B2 (en) 2010-06-29 2021-04-13 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10966644B2 (en) 2010-06-29 2021-04-06 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US11051724B2 (en) 2011-12-11 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US11051725B2 (en) 2011-12-11 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US11179068B2 (en) 2011-12-11 2021-11-23 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9693713B2 (en) 2011-12-11 2017-07-04 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9931066B2 (en) 2011-12-11 2018-04-03 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
USD915601S1 (en) 2011-12-11 2021-04-06 Abbott Diabetes Care Inc. Analyte sensor device
USD903877S1 (en) 2011-12-11 2020-12-01 Abbott Diabetes Care Inc. Analyte sensor device
USD915602S1 (en) 2011-12-11 2021-04-06 Abbott Diabetes Care Inc. Analyte sensor device
US11612363B2 (en) 2012-09-17 2023-03-28 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US10036709B2 (en) 2014-05-20 2018-07-31 Roche Diabetes Care, Inc. BG meter illuminated test strip
USD980986S1 (en) 2015-05-14 2023-03-14 Abbott Diabetes Care Inc. Analyte sensor inserter
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11512384B2 (en) 2017-05-11 2022-11-29 Medtronic Minimed, Inc. Analyte sensors and methods for fabricating analyte sensors
CN110678122B (en) * 2017-05-11 2023-09-15 美敦力泌力美公司 Analyte sensor and method for producing an analyte sensor
CN110678122A (en) * 2017-05-11 2020-01-10 美敦力泌力美公司 Analyte sensor and method for manufacturing an analyte sensor
US20180328877A1 (en) * 2017-05-11 2018-11-15 Medtronic Minimed, Inc. Analyte sensors and methods for fabricating analyte sensors
WO2018208357A1 (en) * 2017-05-11 2018-11-15 Medtronic Minimed, Inc. Analyte sensors and methods for fabricating analyte sensors
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter
USD1006235S1 (en) 2020-12-21 2023-11-28 Abbott Diabetes Care Inc. Analyte sensor inserter

Also Published As

Publication number Publication date
EP0730037B1 (en) 2001-12-12
DE69617771D1 (en) 2002-01-24
DE69617771T2 (en) 2002-08-08
CN1146016A (en) 1997-03-26
EP0730037A2 (en) 1996-09-04
CN1098459C (en) 2003-01-08
EP0730037A3 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
US5651869A (en) Biosensor
EP0795748B1 (en) Biosensor and method for quantitating biochemical substrate using the same
US5582697A (en) Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US7060168B2 (en) Biosensor
US6458258B2 (en) Biosensor
US5650062A (en) Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
JP3267936B2 (en) Biosensor
JP2760234B2 (en) Substrate concentration measurement method
EP0560336A1 (en) A catalyst made from phosphate and a biosensor including the same
EP0502504B1 (en) A biosensor utilizing enzyme and a method for producing the same
JP3267933B2 (en) Substrate quantification method
JP3794046B2 (en) Biosensor and biosensor for blood glucose level measurement
JP2001249103A (en) Biosensor
JP2000081408A (en) Biosensor
JP3429581B2 (en) Biosensor
JPH0783872A (en) Biosensor and manufacture thereof
JP3245103B2 (en) Biosensor and Substrate Quantification Method Using It
JP3297623B2 (en) Biosensor
JPH10104192A (en) Biosensor
JPH09229895A (en) Biosensor
JPH09304329A (en) Biosensor and substrate determination method using it

Legal Events

Date Code Title Description
AS Assignment

Owner name: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YOSHIOKA, T.;IKEDA, S.;NANKAI, S.;REEL/FRAME:007875/0355

Effective date: 19960213

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: PANASONIC CORPORATION, JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.;REEL/FRAME:032332/0082

Effective date: 20081001

AS Assignment

Owner name: PANASONIC HEALTHCARE CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PANASONIC CORPORATION;REEL/FRAME:032360/0795

Effective date: 20131127

AS Assignment

Owner name: PANASONIC CORPORATION, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PANASONIC HEALTHCARE CO., LTD.;REEL/FRAME:032480/0433

Effective date: 20140301

AS Assignment

Owner name: PANASONIC HEALTHCARE HOLDINGS CO., LTD., JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:PHC HOLDINGS CO., LTD.;REEL/FRAME:032785/0563

Effective date: 20140331

Owner name: PHC HOLDINGS CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PANASONIC CORPORATION;REEL/FRAME:032785/0498

Effective date: 20140331